16006-Lung Cancer-NSCLC-289

Lung Cancer

A Phase II single-arm trial to investigate tepotinib inadvanced (Stage IIIB/IV) non-small cell lung cancerwith MET exon 14 (METex14) skipping alterations or MET amplification(VISION): MS200095-0022

  • Details

ClinicalTrials.gov ID: NCT02864992
Diagnosis Type: NSCLC
USOR Number:

  • Address

22 W Dry Creek Circle
Littleton, CO 80120
P: (303) 730-4700

Search by practice name, trial titles, indicators and specific disease types.

Find a Location

With more than 2,500 physicians and over 600 treatment locations across the country, the advanced cancer care you need may be available right in your local community from a practice in The US Oncology Network. Search to see if there is a center near you.